Arbuckle Stuart A's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 22, 2023
- Accession no.
- 0001209191-23-011665
- Filed
- Feb 22, 2023
- Trade date
- Feb 17-21, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $705.6K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arbuckle Stuart ACIK 0001557290 | Officer (EVP, COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common Stock | FTax withholdingDisposed | −4,498 | $292.85 | −$1,317,239.3 | 71,107 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −21 | $291.01 | −$6,111.21 | 71,086 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −545 | $292.77F2,F3 | −$159,559.65 | 70,541 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −1,100 | $293.74F2,F4 | −$323,114 | 69,441 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −736 | $294.58F2,F5 | −$216,810.88 | 68,705 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $292.77 (range $292.25 to $293.07).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $293.74 (range $293.30 to $294.19).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $294.58 (range $294.36 to $294.96).
Referenced by the price of 1 transaction in Table I.